Behavioral Health Business May 13, 2024
The number of U.S. children diagnosed with autism has dramatically increased to one child out of every 36, according to a Centers for Disease Control study published last year. That’s nearly double the amount of diagnoses a decade prior.
Meanwhile, most commercial insurance and Medicaid health plans must cover at least some autism treatments, and venture capital investors have poured significant, if ever fluctuating, money into autism care providers.
Each of these factors contributes to a few potentially landmark new treatments for autism. This exceptionally complex condition that cannot currently be diagnosed by a blood test and for which no federally approved treatment exists for its main effects.
Still, these novel treatments do not replace applied behavioral analysis (ABA), a...